This program offers physicians a current, step by step approach to diagnosis and treatment of Hepati...
Lecture on Hepatitis
Gary D. Hammer, MD, Ph.D., Director of Endocrine Oncology Program, discusses the incidence of adrena...
Dr Otis Brawley, Chief Medical Officer of the American Cancer Society, talks about the growing incid...
It is estimated that one in every 10 Americans have Hepatitis C. Known as "a silent killer," many pe...
PubMed |
(0) (0 Votes)
|
Views: (1053) Date: (27-01-09) Pages: () |
Abstract: Incidence of hepatitis C virus infection in burn patients: detection of anti-C100, anti-C33c and anti-Core antibodies. Coursag et P, Lesage G, Simpson B, Mayelo V, Le Cann P. Institut de Virologie de Tours, Facult? de Pharmacie, France. Anti-hepati tis C virus antibodies were searched for in 45 burnt patients, at the time of burn injury and more than 6 months after burn injury. HCV infection was detected in 18% as a consequence of the numerous transfusions of blood or blood derivatives used during the post-burn treatment. Five patients displayed evidence of anti-C100, anti-C33c and anti-Core antibodies together; two patients had only anti-C100 and anti-C33c antibodies, and the last one showed only anti-Core antibodies. Chronic hepatitis was observed in 83% of HCV infections. Kinetics of appearance of anti-HCV antibodies varied between patients. Anti-Core is generally the first to be detected at high levels; however, in at least one case it was detected only two and a half months after C100 and C33c antibodies. PMID: 1668142 [PubMed - indexed for MEDLINE]